Stellah Mpagama
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis (NCT05575518) | Stellah Mpagama | 2023-08-11 |
Track Stellah Mpagama automatically
Every clearance here is in the API, with alerts when new ones post.